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Drosophila melanogaster crammer is a novel cathepsin inhibitor
that is involved in LTM (long-term memory) formation. The
mechanism by which the inhibitory activity is regulated remains
unclear. In the present paper we have shown that the oligomeric
state of crammer is pH dependent. At neutral pH, crammer is
predominantly dimeric in vitro as a result of disulﬁde bond
formation, and is monomeric at acidic pH. Our inhibition assay
shows that monomeric crammer, not disulﬁde-bonded dimer, is
a strong competitive inhibitor of cathepsin L. Crammer is a
monomeric molten globule in acidic solution, a condition that
is similar to the environment in the lysosome where crammer is
probablylocated.UponbindingtocathepsinL,however,crammer
undergoesamoltenglobule-to-orderedstructuraltransition.Using
high-resolution NMR spectroscopy, we have shown that a
cysteine-to-serine point mutation at position 72 (C72S) renders
crammer monomeric at pH 6.0 and that the structure of the
C72S variant highly resembles that of wild-type crammer in
complex with cathepsin L at pH 4.0. We have determined the
ﬁrst solution structure of propeptide-like protease inhibitor in its
activeformandexaminedindetailusingavarietyofspectroscopic
methods the folding properties of crammer in order to delineate
its biomolecular recognition of cathepsin.
Key words: cathepsin, crammer, long-term memory (LTM),
molten globule, propeptide-like protease inhibitor.
INTRODUCTION
Drosophila melanogaster has been developed as a model system
for studying learning and memory because of its short lifespan
and the relatively simple and facile nervous system [1,2]. To date,
several genes have been identiﬁed to be involved in the formation
of Drosophila olfactory memory [2–4], but little is known about
the genetic basis and mechanisms that contribute to LTM (long-
term memory) formation. One Drosophila mutant, crammer,
exhibits a speciﬁc LTM defect [5,6]. The overexpression of
crammeringlialcellsimpairsLTM,suggestingthattheexpression
level of crammer is of functional importance with regard to
LTM formation. The crammer gene encodes a cysteine protease
inhibitor, and potential targets include cathepsins. The structural
properties of crammer are hitherto uncharacterized. Crammer
shares approximately 45% primary sequence identity with the
proregionsoftheBombyxmoriandD.melanogaster cysteinepro-
teases, suggesting that crammer belongs to a class of cysteine
protease inhibitors that have propeptide-like inhibitory activity
[7]. Such inhibitors, originally identiﬁed in mouse-activated T-
cells and mast cells, are also known as cytotoxic T-lymphocyte
antigen(CTLA)2α and2β [8],andtheyexhibitinhibitoryactivit-
ies against papain and cathepsin L [9,10]. Similar inhibitors have
also been identiﬁed in other organisms such as B. mori [11–13].
Usingyeasttwo-hybridassay,anumberofcrammer-interacting
proteins have been identiﬁed. These include cathepsins B and L,
and capping protein β [14,15]. Cathepsins are synthesized as
zymogens, each of which contains an N-terminal proregion and a
mature protein sequence. The proregion contains a signal peptide
and a propeptide. The propeptide is required for intracellular
targeting [16], protein folding [17] and enzyme inhibition [18].
Removal of the propeptide by other proteases [19,20] or by
autocleavage at acidic pH [21] activates cathepsins. As the
name suggests, inhibition by a propeptide-like protease inhibitor
is linked to its sequence and/or structural similarity to the
proregionofitstargetprotease.CrammercontainsaGNFDmotif,
GXNX(F/L)XD, which is highly conserved among propeptide-
likeinhibitors[13]andisfoundintheproregionsofmostcysteine
proteases [22]. The GNFD motif is essential for auto-activation
and protein folding [22], but its inhibitory role by propeptide-
like inhibitors is unclear. Crammer also contains a consensus
ERFNINmotif,EX3RX3(F/Y)X2(N/S)X3IX3N,whichisessential
for protease inhibition [8,9]. Finally, crammer contains a
conserved motif at the N-terminus, YKX4KXY, which serves as
a lysosomal-targeting sequence [23,24], suggesting that crammer
is a lysosomal protein.
Despite the biological signiﬁcance of propeptide-like protease
inhibitors, there has hitherto been no structural information
available. Although monomeric and dimeric crammer have been
reported to inhibit cathepsin [15], the molecular mechanism of
its inhibitory mechanism remains elusive. To clarify how the
structureofcrammerrelatestoitsfunction,inthepresentpaperwe
report detailed enzyme kinetic analysis and the solution structure
of crammer using heteronuclear NMR spectroscopy. In light of
the emerging roles of cathepsins B and L in neurodegenerative
diseases [25–27], understanding the molecular basis of the
protease inhibitory activity of crammer will provide valuable
insight into the development of treatments for these diseases.
Abbreviations used: ANS, 8-anilinonaphthalene-l-sulfonic acid; BMRB, BioMagResBank; DTT, dithiothreitol; E-64, trans-epoxysuccinyl-L-leucylamido-
(4-guanidino)butane; HSQC, heteronuclear single quantum correlation; IPTG, isopropyl β-D-thiogalactopyranoside; LTM, long-term memory; NOE, nuclear
Overhauser effect; hetNOE, heteronuclear NOE; NOESY, nuclear Overhauser enhancement spectroscopy; SEC, size-exclusion chromatography.
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The structural co-ordinates reported will appear in the PDB under accesion code 2L95.
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EXPERIMENTAL
Materials
ANS (8-anilinonaphthalene-l-sulfonic acid) and E-64 [trans-
epoxysuccinyl-L-leucylamido-(4-guanidino)butane] were pur-
chased from Sigma–Aldrich. 2-Mercaptoethanol, chloramphen-
icol and sodium azide were supplied by Merck Research
Laboratories. Ampicillin, DTT (dithiothreitol) and IPTG
(isopropyl β-D-thiogalactopyranoside) were obtained from
MDBio (Taipei, Taiwan). EDTA and Blue Dextran 2000 were
purchased from USB. Glacial acetic acid and Triton X-100
were supplied by ECHO Chemical and Amresco respectively.
All chemicals were of analytical grade.
Protein expression and puriﬁcation
A two-step PCR was used to synthesize the crammer gene [28].
The primers were obtained from Mission Biotechnology. The
crammer gene was assembled and ampliﬁed by PCR [28].
The ﬁnal product was cloned into a pAED4 vector (Dr Min
Lu, Weill Medical College of Cornell University, New York,
NY, U.S.A.) and expressed in Escherichia coli Rosetta (DE3)
strain (Merck). Site-speciﬁc point mutations were prepared with
the QuikChange site-directed mutagenesis kit (Stratagene) and
expressed and puriﬁed following the same protocol as described
for wild-type crammer. The sequences of the recombinant genes
were veriﬁed by DNA sequencing (Mission Biotechnology).
E. coli cells harbouring pAED4 that contain the crammer or
mutant genes were cultured in Luria-Bertani medium containing
100 mg/ml ampicillin and 30 mg/ml chloramphenicol at 37◦C
until the D600 value of the culture reached 0.7. IPTG (ﬁnal
concentration, 1 mM) was added to the cell culture to initiate
recombinant protein overexpression.
15N-labelled and
15N/
13C-
labelled crammer samples were obtained from E. coli cultures
incubated in M9 medium containing (1 g/l)
15NH4Cl and/or
(2 g/l) [
13C]glucose/
15NH4Cl (Cambridge Isotope Laboratories)
[29]. Whole cells were lysed with glacial acetic acid and
centrifuged at 30700 g for 20 min at 4◦C to remove the cell
debris. The supernatant was dialysed against MilliQ water, and
the precipitate was removed by centrifugation (30700 g for
10 min at 4◦C). Recombinant crammer was puriﬁed by an 1100
Series RP-HPLC system (Agilent Technologies) using a C18
semi-preparative column (Nacalai). A linear water/acetonitrile
gradient (29–37%) was used for protein separation, and puriﬁed
protein fractions were characterized by an Autoﬂex III MALDI–
TOF (matrix-assisted laser-desorption ionization–time-of-ﬂight)
mass spectrometer (Bruker Daltonics). Protein concentrations
were determined using the Protein Assay reagents (Bio-Rad
Laboratories)andbovineserumalbuminofknownconcentrations
as the calibration standards.
Characterization of the oligomeric states of crammer
Puriﬁed crammer (∼1 mg) was dissolved in buffers of varying
pH values [50 mM citric acid-sodium phosphate (pH 3.0–5.0),
or 50 mM Tris/HCl (pH 6.0–8.0)] for SEC (size-exclusion
chromatography) analysis. The protein samples were loaded on
to a 16/60 Superdex 75 pg column connected to an FPLC system
(AKTAprime, Amersham Biosciences). To identify the oligo-
meric state of crammer in vivo, crammer was extracted from the
heads of wild-type D. melanogaster, which were frozen in liquid
nitrogen and detached from the ﬂy bodies by vigorously shaking
with pre-chilled 25- and 40-mesh sieves. The frozen heads were
pulverized and suspended in 50 mM sodium acetate (pH 5.0),
containing1 mMEDTA,0.1%TritonX-100and0.5 mMsodium
Table 1 NMR constraints and structural statistics for C72S
RMSD, root mean square deviation.
Distance constraints
Total NOE 859
Intraresidue 341
Sequential (|I–J|=1) 184
Medium range (|I–J|4) 78
Long range (|I–J|>4) 61
Hydrogen bond constraints 61
Total dihedral angle constraints 134
  67
  67
RMSD (A ˚) with respect to the average structure
Well-deﬁned regions (residues 8–49 and 52–74)
Backbone 0.4+ −0.1
Heavy atoms 0.8+ −0.2
All residues (residues 1–80)
Backbone 1.9+ −0.4
Heavy atoms 2.2+ −0.4
Total energy after water reﬁnement (kcal/mol) −2700+ −100
RMSD from idealized covalent geometry
Bonds (A ˚) 0.0153+ −0.0005
Angles (◦)2 . 1 0 + −0.07
Impropers (◦)2 . 6 + −0.1
Ramachandran statistics
Most favoured regions 85.2%
Additionally allowed regions 13.6%
Generously allowed regions 1.1%
Disallowed regions 0.0
BioMagResBank accession code 16719
PDB code 2L95
azide [15,30]. A polyclonal antibody against crammer (LTK Bio-
Laboratories) was used to probe the oligomeric state of crammer.
Spectroscopic characterization of crammer
Far-UVCDspectrawereacquiredusinganAvivCDspectrometer
(Model 202, Aviv Biomedical). Wild-type crammer and C72S
were buffered in 10 mM citric acid-sodium phosphate (pH 2.0–
12.0) and the protein concentrations were set to 30 μM. The far-
UV CD spectra were recorded at 20◦C with a wavelength range
between 260 and 190 nm, using a 1-mm path length cuvette. The
helical contents of the samples were estimated using the CDNN
software [31]. Thermal denaturation of crammer was carried out
by recording a series of CD spectra from 4◦Ct o9 6 ◦C, with an
increment of 2◦C. Intrinsic ﬂuorescence of C72S (0.02 mg/ml)
were recorded as a function of pH using a ﬂuorimeter (F-7000,
Hitachi) between 290 and 400 nm (λex =280 nm). For ANS
ﬂuorescencemeasurementsasafunctionofpHvalues,theprotein
concentrations were 30 μM and that of ANS was 20 μM. The
wavelength range was set to 385–600 nm (λex =365 nm).
NMR spectroscopy
Uniformly
13C/
15N-labelled crammer (0.3 mM) was buffered in
10 mMcitricacid-sodiumphosphatecontaining10%(v/v)
2H2O.
The pH values of the samples were adjusted prior to NMR
measurements at 25◦C using AVANCE NMR spectrometers
(BrukerSpectrospin)operatingat
1HLarmorfrequenciesof500or
600MHz,andaVarianINOVANMRspectrometerequippedwith
a cryogenic probe head and operating at the
1H Larmor frequency
of 700 MHz. The spectra were processed using TopSpin (Bruker
Spectrospin), NMRPipe [32] and Sparky (T. D. Goddard and
D. G. Kneller, University of California, San Francisco).
1H,
13Ca n d
15N backbone and side-chain resonance assignments
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Figure 1 Crammer dimerization as a function of pH
(A)SECisusedtomonitorthedimerizationofcrammerasafunctionofpH.BlueDextran2000astheinternalstandardiselutedatthevoidvolume.Molecularmassstandards:1,chymotrypsinogenA
(25kDa)and2,RNaseA(13.7kDa).(B)13%(w/v)Tricine-SDS/PAGE.Lane1containsmolecularsizemarkers(M).LaneslabelledmonomeranddimerareHPLC-puriﬁedproteins,andtheproteins
contained in last two lanes are as labelled in the Figure. β-ME, 2-mercaptoethanol. (C) The results from SEC and Tricine-SDS/PAGE suggest that C72S at neutral pH exists in a monomeric form.
(D) Crammer extracted from Drosophila heads is monomeric in the absence of 2-mercaptoethanol. The control lane labelled ‘crammer’ contains the recombinant protein, which exists as both
monomer and dimer as visualized by the antibody against crammer. In (B)a n d( D) the molecular mass is given in kDa on the left-hand side. AU, arbitrary unit.
for spectra of crammer at pH 3.0 and pH 6.0 were obtained
from a set of heteronuclear multidimensional NMR spectra
[33,34]. Secondary structure propensity was calculated using
the SSP program [35] using the assigned
13Cα,
13Cβ and
13C’
chemical shifts. For the hetNOE [heteronuclear NOE (nuclear
Overhauser effect)] experiments,
1H presaturation was achieved
using a train of weak saturation pulse intervals during the 5-s
recycle delay. The hetNOE value is deﬁned as the ratio of the
peak intensities recorded with and without
1H saturation, i.e.
hetNOE=I
sat/I
ref,w h e r eI
sat is the peak intensity with saturation,
and I
ref is the peak intensity without saturation [36]. To study
the binding of crammer to Drosophila cathepsin L, the
1H-
15N-
HSQC (heteronuclear single quantum correlation) spectrum of
15N-labelled crammer and an excess of Drosophila cathepsin
L in 10 mM citric acid/sodium phosphate buffer (pH 4.0) was
recorded.
Solution structure determination
15N- and
13C-edited NOESY-HSQC spectra of crammer were
recorded at pH 6.0 to obtain distance constraints through
manual assignments of the NOE cross-peaks (Table 1). The
chemical shifts of the
1H
N,
15N,
1Hα,
13Cα,
13Cβ and
13C’
resonances were used as the inputs for TALOS+ [37] to
obtain backbone torsion angle constraints. CNS 1.1 was used
for restrained molecular dynamics simulations to generate the
solution structures [38]. The ﬁnal ensemble consists of 11 lowest
energystructuresandwasevaluatedusingthePROCHECK-NMR
package [39] and Discovery Studio 2.0 (Accelrys). The solvent
accessibility was calculated using Discovery Studio 2.0. PyMOL
(http://www.pymol.org) was used for molecular visualization.
Inhibition assay
The cathepsin-inhibition assay was carried out according to the
procedure described by Comas et al. [5]. SEC was used to
purify cathepsin from Drosophila heads. Each SEC fraction
was subject to protease activity assays using Z-Phe-Arg-
AMC as substrate (Calbiochem) [40,41]. The amount of
released AMC was measured by its ﬂuorescence emission at
440 nm (λex =380 nm). The puriﬁed Drosophila cathepsin was
identiﬁed using cathepsin B/L speciﬁc inhibitors [15,42,43]
and the enzymatically active substance in the Drosophila head
extract was mainly cathepsin L (Supplementary Figure S1
at http://www.BiochemJ.org/bj/442/bj4420563add.htm). Out of
6go fDrosophila heads, we could obtain about 1 mg of active
cathepsin L. We also constructed and expressed recombinant
Drosophila cathepsin B using an E. coli expression system (de-
scribed in detail in the Supplementary online data at http://www.
BiochemJ.org/bj/442/bj4420563add.htm). The concentrations of
activeDrosophilacathepsinsLandBweredeterminedusingE-64
[44]. For the inhibition assays, 70 mg of recombinant crammer
was dissolved in 10 mM citric acid/sodium phosphate (pH 4.0)
to yield a stock solution of 0.5 mM. Various concentrations
of crammer taken from a stock solution were incubated
with cathepsin (40 nM) in 100 mM sodium acetate (pH 5.0),
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Figure 2 Inhibitory activity of crammer against Drosophila cathepsin L
(A) Plot of the initial rate (V0) compared with crammer concentration. Monomeric crammer markedly inhibits Drosophila cathepsin L. (B) Dixon plot analysis of inhibition of Drosophila
cathepsin L. This analysis is used to determine the inhibition constant (Ki) of the monomeric crammer. (C) Michaelis–Menten kinetics. Lineweaver–Burk analysis is utilized to determine kinetic
parameters for Drosophila cathepsin L inhibition. The Km value for cathepsin L increases in the presence of crammer, whereas the Vmax value is unchanged.
containing 1 mM EDTA and 2 mM DTT. Z-Phe-Arg-AMC
(18 μM) was then added to detect residual enzyme activity.
Michaelis–Menten kinetics was used to determine the values
of Km and Vmax of Drosophila cathepsin L in the presence or
absence of crammer. The concentration of crammer was 10 nM.
The non-linear curves were ﬁt using KaleidaGraph (Synergy
Software).
RESULTS
Oligomeric state of crammer
Crammer has been reported to be either monomeric or dimeric
[15], but the underlying mechanism for the monomer–dimer
switch is hitherto unclear. We ﬁrst examine the oligomeric state
of crammer as a function of pH. SEC analysis reveals that
crammer is predominately monomeric under acidic conditions,
and it is dimeric at neutral and basic pH values (Figure 1A). After
incubation with excess 2-mercaptoethanol, the dimeric form of
wild-type crammer is dissociated into monomers as shown by
Tricine-SDS/PAGE (Figure 1B). To conﬁrm that the dimerization
of crammer is a result of disulﬁde bond formation, we replace
the only cysteine residue at position 72 with a serine, C72S, and
indeed the dimeric form of crammer is no longer present in the
SDS/PAGE gel (Figures 1B and 1C). An Ellman assay [45,46]
shows that monomeric crammer has high free thiol content, but
dimericcrammerdoesnot(resultsnotshown).Takentogether,we
conclude that dimeric crammer resulted from the formation of an
intermolecular disulﬁde bond between crammer monomers. To
investigate the oligomeric state of crammer in vivo, endogenous
crammer was extracted from wild-type Drosophila heads and
probed by Western blotting in the absence of 2-mercaptoethanol,
and the results indicate that endogeneous crammer is monomeric,
not dimeric, in vivo (Figure 1D).
Inhibitory assay
Deshapriya et al. [15] reported that both monomeric and
dimeric crammer exhibit protease-inhibitory activity. To allow
comparison of their results with those of the present study,
recombinant crammer was incubated with Drosophila cathepsin
L puriﬁed from ﬂy head extracts to examine the enzyme
activity (Figure 2A) following the protocol reported by Comas
et al. [5]. The ZFR-AMC enzymatic assay indicates that only
monomeric, not dimeric, crammer exhibits inhibitory activity
against Drosophila cathepsin L. The inhibition of cathepsin L,
monitored by ﬂuorescence, gives a linear plot as a function
of time (Supplementary Figure S2 at http://www.BiochemJ.
org/bj/442/bj4420563add.htm) and a Dixon plot is used to
determine the enzyme-inhibitor inhibition constant (Ki) [5,9,15].
The Ki value for monomeric crammer is 1.36+ −0.67 nM
(Figure 2B), which is comparable with those that have been
reported for other strong cysteine protease inhibitors [9,13,15].
Additionally, recombinant wild-type crammer [5] and C72S in
their monomeric forms also exhibit inhibitory activities against
human cathepsin L (results not shown). Michaelis–Menten
analysis reveals that the addition of crammer increases the
Michaelisconstant(Km)ofDrosophilacathepsinLfrom3.85 μM
to 20.06 μM without affecting the Vmax value (0.006 min
−1)
(Figure2C),whichisahallmarkofcompetitiveinhibition[47].In
summary, monomeric crammer is a strong competitive inhibitor
that blocks the cathepsin substrate-binding site.
Structural characterization
We ﬁrst employed far-UV CD spectroscopy to examine the
structure of crammer. The far-UV CD spectrum of crammer
at pH 7.0 exhibits a strong signal at 222 nm, corresponding
to an α-helical content of 63+ −4%; crammer is less helical
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Figure 3 Spectral properties of crammer
(A) Far-UV CD of crammer at various solution pH values and temperature. WT, wild-type.
Inset: thermal denaturation of crammer and C72S monitored by CD at 208nm. (B) The spectral
properties of C72S as a function of pH monitored by far-UV CD and intrinsic ﬂuorescence
spectroscopy and ANS binding.
at pH 4.0 (34+ −4%; Figure 3A). C72S appears to be slightly
less helical than wild-type crammer at pH 7.0 (54+ −3%), but
its α-helical content is similar to that of crammer at pH 4.0
(33+ −1%). When subject to thermal unfolding, crammer unfolds
more cooperatively at pH 7.0 than it does at pH 4.0 (Figure 3A,
inset) [48]. Interestingly, the secondary structure of C72S is
less sensitive to pH (Figure 3A). For both wild-type and C72S,
the ANS ﬂuorescence negatively correlates with the CD signal
at 222 nm as a function of pH, (Supplementary Figure S3 at
http://www.BiochemJ.org/bj/442/bj4420563add.htm), indicating
that both proteins partially unfold under acidic conditions.
We have employed far-UV CD, intrinsic tryptophan
ﬂuorescence and ANS-binding ﬂuorescence spectroscopy to
systematically monitor the folding of C72S as a function of pH
(Figure 3B). The far-UV CD signal at 222 nm follows a bell-
shaped distribution with a maximum plateau between pH 5 and
8 ﬂanked by signiﬁcant decreases at lower and higher pH values,
suggesting that α-helix formation is associated with salt-bridge
formation [49]. At neutral pH, most ionizable residues should
be ionized, rendering salt-bridge formation more favourable. At
high acidic or basic pH values, salt bridges are less likely to form
due to overall protonation and deprotonation respectively [49].
It is noteworthy that that we observe blue shift of the intrinsic
ﬂuorescenceofC72SonincreasingpHvalues(resultsnotshown),
indicating that the local environments of the aromatic groups
becomemorehydrophobicasaresultofwell-deﬁnedhydrophobic
core formation at neutral pH values [7,50]. This ﬁnding is
corroborated by the ANS data, which probe the extent to which
hydrophobicregionsareexposed(Figure3B)[7,50].AtacidicpH
values, ANS binds strongly to C72S, with ﬂuorescent intensity
peaking at pH 4.0. In the same assay, the ﬂuorescence signal
is lost at neutral pH, indicating the formation of a well-deﬁned
tertiary structure. Collectively, we conclude that crammer retains
signiﬁcant amount of helical structures under acidic conditions,
but lacks a well-deﬁned hydrophobic core as shown by the loss
of cooperativity under thermal unfolding. This is good evidence
to suggest that crammer is in a molten globular state under acidic
conditions [51,52].
Protein folding
In order to obtain structural insight into the structural transition
of crammer at a residue-speciﬁc level, high-resolution NMR
spectroscopywasemployedtoinvestigatethesolutionstructureof
crammer.WehavecarriedoutapHtitrationforC72Sbyrecording
aseriesof
1H-
15NHSQCspectraatdifferentpHvalues(Figure4A
and Supplementary Figure S4 at http://www.BiochemJ.org/
bj/442/bj4420563add.htm).C72Sexhibitspoorlydispersedcross-
peaks at pH 3.0 and 4.0, under which conditions C72S
is predominantly molten globular. The observed resonances
substantially broadened at pH 5.0. At pH values of 6.0 or higher,
a new set of well-dispersed cross-peaks emerge, indicating the
formation of a well-deﬁned tertiary structure upon increase in
pH, which is consistent with the global analysis by far-UV CD,
intrinsic tryptophan ﬂuorescence and ANS binding (Figure 3).
We have assigned the backbone resonances of C72S (H
N,C α,
Cβ, C’ and N) at pH 3.0 to examine the solution structure of
crammer in detail [BMRB (BioMagResBank) accession number
17367]. Although the far-UV CD and intrinsic ﬂuorescence
spectra as well as the chemical shift dispersions in the
1H-
15N
HSQC spectrum all indicate that C72S is largely unfolded at
pH 4.0 and below, the secondary chemical shifts of the Cα,
Cβ, and C’ nuclei at pH 3.0 reﬂect a signiﬁcant proportion
of the molecule, particularly those in the N-terminal region,
which exhibit substantial residual helical content (Figure 4B).
Interestingly,α2shiftssigniﬁcantlyfromresidues22–48(pH 6.0)
to 18–42 (pH 3.0), thus resulting in the connection of α2 with
α1t of o r mal o n gs t r e t c ho fα-helix at pH 3.0. We have
also measured the
1H-
15N hetNOEs of C72S at pH 6.0 and
pH 3.0 to probe fast backbone dynamics on the femtosecond
to picosecond timescale (Figure 4B) [36]. The overall hetNOE
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Figure 4 1H-15N-HSQC Spectra
(A) 1H-15N-HSQC spectra of C72S as a function of pH. The assigned cross-peaks for C72S at pH3.0 and pH6.0 are labelled in the Figure. The inset shows an expanded view of part of the spectrum.
(B) Secondary structure propensity and hetNOEs of C72S residues. Upper panel: secondary structure propensity (SSP) compared with C72S residue number. Red line, pH3.0; black bars, pH6.0.
Positive values indicate α-helical propensity, and negative values indicate β-strand propensity. Lower panel: hetNOE values used to investigate the femtosecond-to-picosecond dynamics of C72S.
Residues in folded regions have larger hetNOE values. The α-helical regions and the salt bridges are depicted schematically at the top of the Figure. (C) 1H-15N-HSQC spectra of wild-type (WT)
crammer (pH4.0) in the absence (black) or presence of Drosophila cathepsin L (red). (D) The spectra of the Drosophila cathepsin L/crammer complex (red) and C72S (blue). The C72S cross-peaks
are labelled.
values are higher at pH 6.0 than those at pH 3.0, with
average values of 0.72+ −0.05 and 0.34+ −0.02 respectively,
indicating that the backbone conformation C72S is much more
ﬂexible, i.e. disordered, at pH 3.0, whereas at pH 6.0 the overall
structure of C72S is compact and well deﬁned. Despite the loss
of compact hydrophobic core, the N-terminal region of C72S,
especially α1a n dt h eﬁ r s th a l fo fα2, exhibits relatively higher
hetNOE values(>0.6)that arecomparablewith thoseobservedat
pH 6.0. Taken together, the NMR data indicate that C72S retains
a substantial amount of helical structure at acidic pH despite an
ill-deﬁned hydrophobic core (Figure 3B), further supporting our
hypothesis that C72S is in a molten globular state under acidic
conditions [53].
Intriguingly, although crammer is largely disordered at pH 4.0,
the addition of cathepsin L puriﬁed from Drosophila head
extract induces a molten globule-to-ordered structure transition
as evidenced by the emergence of well-dispersed
1H-
15NH S Q C
resonances (Figures 4C and 4D). The chemical shifts of these
cross-peaks are very similar to those of C72S at pH 6.0
(Figure 4D), indicating that the solution structure of monomeric
crammer C72S at pH 6.0 resembles that of cathepsin L-bound
(activated) crammer at pH 4.0. We therefore use C72S at pH 6.0
asamimicofcathepsinL-boundedcrammerfordetailedstructural
elucidation in the following section (Table 1).
Solution structure of C72S
We have obtained near complete backbone assignments of C72S
except for those of Glu
8,P r o
65 and Val
76–Asn
79 (>91% of all the
expected H
N,C α,C β, C’ and N resonances). These unassigned
residuesalllayintheloopregionsthatareinherentlyﬂexible.The
correspondingresonancesarebroadenedbeyonddetection,which
we attribute to the result of solvent exchange. The NMR chemical
shift assignments of C72S have been deposited in the BMRB
under accession number 16719. Using
13C/
15N-edited NOESY
spectraandbackbonetorsionanglerestraints,wehavedetermined
the solution structure of C72S (Figure 5A and Table 1) which has
been deposited in the PDB (PDB code 2L95).
The solution structure of C72S contains four α-helices [Asp
6–
Phe
16 (α1), Ala
22–Lys
48 (α2), His
59–Ala
61 (α3) and Pro
65–Arg
71
(α4)]withα2servingasthecorestructurethatappearstomaintain
the overall tertiary structure (Figure 5A). The three-dimensional
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Figure 5 Solution structure of C72S
(A) Stereo view of eleven lowest-energy structures that are superpositioned on their backbone atoms (N, Cα and C’). The helices α1, α2, α3a n dα4 are labelled. The consensus sequence is shown
at the top of the Figure, with the helical regions indicated. (B) Structure of human procathepsin L (PDB code 1CS8). The proregion is shown in ribbon representation. (C) The crammer residues
involved in salt bridges are shown as ball-and-stick representation in the inset. (D) NOE cross-peaks for the charged side-chains that are involved in salt-bridge formation. (E) The aromatic
residues in C72S are shown in spheres to indicate the hydrophobic core packing. The protein surface is shown in white.
fold of crammer is very similar to that of the proregion of
procathepsin L (Figure 5B) [54]. Structural alignment of the two
gives a moderate pairwise positional root mean squared devi-
ation of 4.09 Å (1 Å=0.1 nm) for the Cα atoms within the
secondary structure elements. The deviation is largely due to the
result of different relative orientations of the individual α-helices
(Figure 5A).
There are two salt bridges that connect α1a n dα2 (Asp
6–Arg
29
andGlu
8–Lys
36),andtwothatconnectα2andα4(Glu
24–Arg
28 and
Arg
28–Glu
67 (Figure 5C). Their presence is conﬁrmed by long-
range NOEs between their respective side-chains (Figure 5D).
The ERFNIN motif is located in α2 and is surrounded by α1,
α3, α4 and loop 2, which is a relatively long loop. As ERFNIN
is located in the central region of the core structure, it may be
an important folding element. Also important for folding are
six well-conserved aromatic residues (Trp
9,T y r
12,P h e
16,T y r
20,
Tyr
32 and Phe
68) that form a small hydrophobic core for structure
stabilization (Figure 5E).
To examine the importance of these aromatic residues in
enzyme inhibition, we ﬁrst constructed recombinant Drosophila
cathepsins B and L (see the Supplementary online data).
Recombinant cathepsin L could not be expressed despite the
use of several expression vectors and E. coli strains (results
not shown). We therefore focused on the enzymatic kinetics of
cathepsin B inhibition by different concentrations of crammer
(Figure 6A). On the basis of non-linear regression analysis, the
kobs values exhibit a linear relationship with respect to crammer
concentrations(Figure6B),implyingasingle-step,reversibleand
slow-binding inhibition mechanism [15,55]. Individual alanine
replacements of these aromatic residues decrease the inhibitory
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Figure 6 Inhibitory activities of crammer and its mutants against Drosophila cathepsin B
(A) Progress curves for the cathepsin B inhibition by different concentrations of crammer are non-linear as a function of time, implying a typical slow-binding inhibition. The observed ﬂuorescence
signals are ﬁtted using the equation, [P]=Vs×t +(V0–Vs)×[1−exp(−kobs×t)]/kobs [15,55], where P is the amount of product formed at time t, V0 and Vs are the initial and steady-state
velocities respectively, and kobs is the rate constant for inhibition. (B)P l o to fkobs compared with crammer concentrations for the inhibition of cathepsin B. On the basis of a regression analysis
[15,55],theKi valuescanbeobtained.(C)Plotsoftheinitialratesofﬂuorescenceincreaseasafunctionofinhibitor(crammervariants)concentrations.Theconservedaromaticresiduesarereplaced
with alanine to clarify their potential roles in cathepsin B inhibition.
Table 2 Cathepsin B inhibitor inhibition constants
The Ki values are determined by the V0 and Vs values. N.D., not determined.
Enzyme Crammer W9A Y12A F16A Y20A C72S
Cathepsin B Ki value 0.79+ −0.35μM N.D. 18.94+ −2.24μM2 . 2 6 + −0.23μM5 . 4 0 + −1.25μM1 . 8 7 + −0.63μM
ability (Figure 6C and Table 2). Wild-type crammer displays a
maximal Drosophila cathepsin B inhibition with a Ki value of
0.79+ −0.35 μM. In contrast, W9A, Y12A, and Y20A exhibit
weak or medium inhibition activities. The removal of these
aromaticsidechainsareexpectedtoperturbthehydrophobiccore,
andthelossofstructuralintegrityinturndiminishestheinhibitory
activities against cathepsin B. This is particularly pronounced for
W9A(Figures5and6),lendingsupporttotheimportanceofthese
aromatic residues in protein folding. Finally, Ser
72, located in the
ﬂexible C-terminal region, is more than 95% solvent accessible.
Cys
72 in crammer is also probably highly exposed, which would
allow for intermolecular disulﬁde bond formation.
DISCUSSION
Using Western blotting, we have established that endogenous
crammer (isolated from fruit ﬂy head) is monomeric in vivo
(Figure 1D). Crammer contains a lysosomal-localization motif
(YKX4KXY) that probably targets crammer into the lysosome, a
highly acidic (<pH 5.0) cellular compartment where crammer is
expected to be predominantly monomeric (Figure 1A). Although
Deshapriya et al. [15] reported that both monomeric and dimeric
forms of crammer can inactivate cathepsin, our inhibitory assay
has shown that only monomeric, not dimeric, crammer is a
strong natural inhibitor (nanomolar range) of cathepsin L. Under
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acidic conditions, monomeric crammer contains a substantial
amountofhelicalconformation,butlacksacompacthydrophobic
core (Figures 3 and 4A), indicating that crammer is a molten
globule under acidic conditions. When bound to cathepsin L,
however, crammer adopts an ordered structure that gives rise to
well-dispersed NMR resonances which highly resemble those of
C72S at pH 6.0 (Figures 4C and 4D). Supported by the spectral
similarity,wethereforeuseC72SatpH 6.0tomimicthecathepsin
L-bound form of wild-type crammer at physiological, acidic
conditions, for detailed structural elucidations.
Despite the reports of several cysteine protease structures
[56,57], there is hitherto no structural information of protease
proregions in isolation and that of propeptide-like protease inhi-
bitors. The solution structure of C72S is the ﬁrst high-
resolution structure for a propeptide-like protease inhibitor.
Indeed, the structure of C72S resembles that of the human
cathepsin L proregion (PDB code 1CS8; Figure 5B) [54].
The proregion C-terminal residues of procathepsin L blocks the
cathepsin active site [54], as do those of crammer. The two
structures also share the same topology; however, the sequence
composition and chain length between the two proteins are very
different, as reﬂected by structural differences for α3a n dt h e
N- and C-termini. C72S has an additional helical segment (α3),
encompassing residues 59–61, that is absent in the proregion
of human cathepsin L. In particular, the C-terminal tail of the
proregion is longer and is free of cysteine.
Human cathepsins B and L have been associated with certain
neurodegenerative diseases, e.g. Parkinson’s disease [58]. In
the fruit ﬂy, the overexpression of crammer impairs LTM
[5,6], providing evidence of causal relationship between cysteine
protease activities and neurophysiology in humans and ﬂies. In
general, activation of human cathepsin requires cleavage of its
proregion at acidic pH [59]. When cleaved, the proregion exists
as a molten globule [60], as we have shown here for crammer
under acidic conditions. Nonetheless, the cleaved proregion does
not inactivate cathepsin [61]. Although much experimental work
is required to further establish the activation mechanism of
Drosophila cathepsin, our data and that of others have suggested
that human and Drosophila cathepsins may be activated by the
same mechanism.
Ourbioinformaticanalysissuggeststhatcrammerislocalizedin
the lysosome. Although both crammer and the cleaved proregion
of human cathepsin share molten globule-like structural features
under acidic conditions in vitro, crammer is a strong inhibitor of
cathepsin under acidic conditions, whereas the proregion is not
[61]. Importantly, the tight binding of crammer to cathepsin is
associated with a molten globule-to-ordered structure transition.
It remains to be seen if such a structural transition occurs when
otherpropeptide-likeproteaseinhibitorsbindtotheirtargets.This
structural transition is also regulated by pH. Once crammer is
in other organelles with higher pH values, crammer probably
presents as an inactive dimer against cathepsin. Hence, the
switch from monomeric to dimeric crammer is probably an
alternative mechanism for the cathepsin regulation. This pH-
mediated regulation is also observed in other proteins [62].
However, the detailed molecular mechanism of this regulation
in crammer requires further investigation.
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EXPERIMENTAL
Expression and puriﬁcation of Drosophila cathepsin B
The Drosophila cathepsin B gene was ampliﬁed from
cDNA libraries using the primers 5
 -CGGATCCGACCCGA-
TGAATCTATTGCTCCTG-3
  (BamHI restriction site under-
lined)and5
 -GATCTCGAGTTACAGCTTGGGCAGACCCGCC-
3
  (XhoI restriction site underlined). The PCR ampliﬁcation
program was performed by 29 cycles of 30 s at 95◦C, 30 s at
54◦C and 1 min at 72◦C. The PCR product was cloned into a
pET-32a(+) vector (Novagen) to obtain a Drosophila cathepsin
B construct containing a proregion and a mature protein. The
sequence of the recombinant genes was veriﬁed by DNA
sequencing (Mission Biotechnology).
E. coli BL21-Gold® (DE3) cells (Stratagene) harbouring a
plasmid with the Drosophila cathepsin B gene were cultured in
Luria–Bertani medium containing 50 mg/ml ampicillin at 37◦C
until the D600 value of the culture was 0.6. The protein was
then expressed by adding IPTG (ﬁnal concentration = 1m M ) .
Whole cells were then harvested by centrifugation at 4000 g for
20 min, and lysed by sonication. The lysates were centrifuged at
16000 g for 20 min at 4◦C. The supernatant was removed and
the precipitate was resuspended in 20 ml of 6 M guanidine buffer
[50 mM Tris/HCl (pH 8.0), 150 mM NaCl, 5 mM EDTA, 10 mM
DTT and6 MGdnHCl (guanidiniumchloride)].Thesolution was
then diluted into 1 litre of 50 mM Tris/HCl (pH 8.5), 150 mM
NaCl, 5 mM EDTA, 10 mM reduced glutathione, 1 mM oxidized
glutathione and 0.5 M arginine overnight. After refolding, the
protein solution was concentrated and dialysed against 25 mM
NaH2PO4 (pH 7.0) and 0.5 M NaCl at 4◦C. To autoprocess
cathepsin B, the protein solution was adjusted to pH 4.5 with
acetic acid, and 5 mM EDTA and 5 mM DTT were added into a
solution to incubate at 37◦Cf o r1h .
Proteins were puriﬁed by an AKTAprime system with a
HiPrep® Sephacryl S-100 high-resolution gel-ﬁltration column
(Amersham Biosciences). The running buffer was 100 mM
sodium acetate buffer (pH 5.0), containing 1 mM EDTA and
2 mM DTT. Each fraction was identiﬁed using Z-Phe-Arg-AMC
substrate (Calbiochem) to conﬁrm the cathepsin B activity.
1 These authors contributed equally to this work
2 Correspondence may be addressed to either of these authors (email lslpc@life.nthu.edu.tw or sthsu@gate.sinica.edu.tw).
The structural co-ordinates reported will appear in the PDB under accesion code 2L95.
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Figure S1 Progress curves for the inhibition of cathepsins
To identify the active substance in our Drosophila head extract, we used cathepsin B/L-speciﬁc inhibitors. A cathepsin L-speciﬁc inhibitor (S3576,
{tert-butyl-[(2S)-1-{2-[2-(2-ethylanilino)-2-oxoethyl]sulfanylcarbonylhydrazinyl}-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamate} shows strong inhibition against the Drosophila head
extract (left-hand panel). The same use of S3576 does not inhibit recombinant Drosophila cathepsin B (right-hand panel). In contrast, the cathepsin B-speciﬁc inhibitor {CA074,
[L-3-trans-(propylcarbamyl)oxirane-2-carbonyl]- L-isoleucyl-L-proline} exhibits opposite results in the same assay. This indicates that the enzymatically active substance in the Drosophila head
extract is mainly cathepsin L.
Figure S2 Progress curves for the inhibition of cathepsin L by crammer
Progress curves for the inhibition of Drosophila cathepsin L in the presence of various
concentrations of crammer gave linear plots, suggesting a concentration-dependent inhibition
of initial velocity of product formation. The crammer concentrations are labelled in the Figure.
Figure S3 ANS binding
The exposure of hydrophobic core was investigated by ANS ﬂuorescence spectra. The ANS
intensity was recorded from 400 to 600nm (λex = 365nm).
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Figure S4 1H-15N-HSQC spectra of C72S as a function of pH
All spectra were recorded at 25◦C, and the assigned cross-peaks for crammer at pH3.0 and pH6.0 are labelled in the Figure. The insert in the upper-left-hand panel shows an expanded viewo fp a r t
of the spectrum.
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